are glp-1 agonists safe receptor GLP-1 Medications for Weight Loss:
Description
Abdul-Ghani MA, Williams K, Kanat M, Altuntas Y, DeFronzo RA

In this randomized, double-blind, placebo-controlled, 3-week crossover trial, 34 patients with primary polydipsia received weekly dulaglutide (1.5 mg, Trulicity) in one treatment segment and placebo (0.9% sodium chloride) in the other

This results in a decrease in the frequency and amplitude of GnRH pulses and a reduction in gonadotropin levels
35 In a retrospective, singlecentre study by Goncalves and Bell, 40 patients who were switched from liraglutide 1.8 mg (used for an average of 210 weeks) to OW semaglutide (average dose 0.76 mg) in clinical practice in the USA were followed for an average of 34 weeks
Yeah, all of them

Medicine 96 , e8952 (2017)
